Larissa Ishikawa

Dr. Larissa Ishikawa

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
GCGiacomo Casella
Giacomo Casella
JRJavad Rasouli
Javad Rasouli
ABAlexandra Boehm
Alexandra Boehm
WZWeifeng Zhang
Weifeng Zhang
DXDan Xiao
Dan Xiao
ARAbdolmohamad Rostami
Abdolmohamad Rostami
Extracellular vesicles from oligodendrocytes restore antigen-specific immune tolerance in mice models of multiple sclerosis.

2 August 2016 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
LILarissa Ishikawa
Larissa Ishikawa
PCPriscila Maria Colavite
Priscila Maria Colavite
Thais Fernanda de Campos Fraga-SilvaThais Fernanda de Campos Fraga-Silva
Thais Fernanda de Campos Fraga-Silva
LMLuiza Ayumi Nishiyama Mimura
Luiza Ayumi Nishiyama Mimura
TFThais Graziela Donegá França
Thais Graziela Donegá França
ASAlexandrina Sartori
Alexandrina Sartori

12 May 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FCFernanda Chiuso-Minicucci
Fernanda Chiuso-Minicucci
LILarissa Ishikawa
Larissa Ishikawa
LMLuiza Ayumi Nishiyama Mimura
Luiza Ayumi Nishiyama Mimura
Thais Fernanda de Campos Fraga-SilvaThais Fernanda de Campos Fraga-Silva
Thais Fernanda de Campos Fraga-Silva
TFThais Graziela Donegá França
Thais Graziela Donegá França
ASAlexandrina Sartori
Alexandrina Sartori
Experimental autoimmune encephalomyelitis (EAE) is an animal model to study multiple sclerosis (MS). Considering the tolerogenic effects of active vitamin D, we evaluated the therapeutic effect of myelin oligodendrocyte glycoprotein (MOG) associated with active vitamin D in EAE development. EAE was induced in female C57BL/6 mice by immunization with MOG emulsified with Complete Freund’s Adjuvant plus Mycobacterium tuberculosis. Animals also received two intraperitoneal doses of Bordetella pertussis toxin. One day after immunization, mice were treated with 0,1μg of 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) every other day during 15 days (on days 1, 3, 5, 7, 9, 11, 13 and 15). MOG (150μg) was co-administered on days 3 and 11. The administration of 1,25(OH) 2D3 or MOG determined significant reduction in EAE incidence and in clinical scores. When MOG was associated with 1,25(OH) 2D3 the animals did not develop EAE. Spleen and central nervous system (CNS) cell cultures from this group produced less IL-6 and IL-17 upon stimulation with MOG in comparison to the EAE control group. In addition, this treatment inhibited dendritic cells maturation in the spleen and reduced inflammatory infiltration in the CNS. The association of MOG with 1,25(OH) 2D3 was able to control EAE development.

15 November 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
WZWeifeng Zhang
Weifeng Zhang
DXDan Xiao
Dan Xiao
XLXing Li
Xing Li
YZYuan Zhang
Yuan Zhang
JRJavad Rasouli
Javad Rasouli
GZGuang-Xian Zhang
Guang-Xian Zhang
Astrocytes are highly heterogeneous in their phenotype and function, which contributes to CNS disease, repair, and aging; however, the molecular mechanism of their functional states remains largely unknown. Here, we show that activation of sirtuin 1 (SIRT1), a protein deacetylase, played an important role in the detrimental actions of reactive astrocytes, whereas its inactivation conferred these cells with antiinflammatory functions that inhibited the production of proinflammatory mediators by myeloid cells and microglia and promoted the differentiation of oligodendrocyte progenitor cells. Mice with astrocyte-specific Sirt1 knockout (Sirt1–/–) had suppressed progression of experimental autoimmune encephalomyelitis (EAE), an animal model of CNS inflammatory demyelinating disease. Ongoing EAE was also suppressed when Sirt1 expression in astrocytes was diminished by a CRISPR/Cas vector, resulting in reduced demyelination, decreased numbers of T cells, and an increased rate of IL-10–producing macrophages and microglia in the CNS, whereas the peripheral immune response remained unaffected. Mechanistically, Sirt1–/– astrocytes expressed a range of nuclear factor erythroid–derived 2–like 2 (Nfe2l2) target genes, and Nfe2l2 deficiency shifted the beneficial action of Sirt1–/– astrocytes to a detrimental one. These findings identify an approach for switching the functional state of reactive astrocytes that will facilitate the development of astrocyte-targeting therapies for inflammatory neurodegenerative diseases such as multiple sclerosis.

1 January 2013 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
SZSofia Fernanda Gonçalves Zorzella-Pezavento
Sofia Fernanda Gonçalves Zorzella-Pezavento
FCFernanda Chiuso-Minicucci
Fernanda Chiuso-Minicucci
TFThais Graziela Donegá França
Thais Graziela Donegá França
LILarissa Ishikawa
Larissa Ishikawa
LRLarissa Camargo da Rosa
Larissa Camargo da Rosa
ASAlexandrina Sartori
Alexandrina Sartori
Experimental autoimmune encephalomyelitis (EAE) is an artificially induced demyelination of the central nervous system (CNS) that resembles multiple sclerosis in its clinical, histopathological, and immunological features. Activated Th1 and Th17 cells are thought to be the main immunological players during EAE development. This study was designed to evaluate peripheral and local contribution of IL-17 to acute and chronic EAE stages. C57BL/6 mice were immunized with MOG plus complete Freund’s adjuvant followed by pertussis toxin. Mice presented an initial acute phase characterized by accentuated weight loss and high clinical score, followed by a partial recovery when the animals reached normal body weight and smaller clinical scores. Spleen cells stimulated with MOG produced significantly higher levels of IFN-γduring the acute period whereas similar IL-17 levels were produced during both disease stages. CNS-infiltrating cells stimulated with MOG produced similar amounts of IFN-γbut, IL-17 was produced only at the acute phase of EAE. The percentage of Foxp3+ Treg cells, at the spleen and CNS, was elevated during both phases. The degree of inflammation was similar at both disease stages. Partial clinical recovery observed during chronic EAE was associated with no IL-17 production and presence of Foxp3+ Treg cells in the CNS.

11 May 2016 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
RTRodolfo Thome
Rodolfo Thome
ACAna Carolina de Carvalho
Ana Carolina de Carvalho
TCThiago Alves da Costa
Thiago Alves da Costa
LILarissa Ishikawa
Larissa Ishikawa
Thais Fernanda de Campos Fraga-SilvaThais Fernanda de Campos Fraga-Silva
Thais Fernanda de Campos Fraga-Silva
LVLIANA VERINAUD
LIANA VERINAUD